No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Simponi is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is a monoclonal antibody that works by blocking the action of tumor necrosis factor (TNF), a protein that plays a role in inflammation. Simponi is administered as an injection or infusion and is available in both brand-name and generic forms.
The Simponi market is a subset of the larger immune disorders drugs market. It is a highly competitive market, with several major players offering similar products. The market is expected to grow in the coming years, driven by increasing prevalence of immune disorders and the introduction of new treatments.
Companies in the Simponi market include Janssen Biotech, Inc., Merck & Co., Inc., Pfizer, Inc., and AbbVie, Inc. Show Less Read more
